ARVN
Arvinas, Inc.$7.63+0.54 (+7.55%)Prev Close$7.09·MCap$478.7M·P/E—·Vol644.3K·Yield—
▲
Buys (12M)
2
$495.1K
▼
Sells (12M)
19
$1.42M
◆
Net Activity
Net Seller
$922.8K
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Arvinas, Inc. (ARVN) has been dominated by selling, with 2 insider purchases totaling $495.1K and 19 insider sales totaling $1.42M. The most recent insider transaction was by Teel Randy (director, officer: President and CEO), who sold $20.0K worth of shares on May 22, 2026. Arvinas, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $478.7M.
ARVN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | Teel Randy | director, officer: President and CEO | Sell | 2,209 | $9.04 | $20.0K | 285,009 |
| May 13, 2026 | Loomis David K | officer: VP, Chief Accounting Officer | Sell | 1,919 | $9.94 | $19.1K | 40,193 |
| May 13, 2026 | Saik Andrew | officer: Chief Financial Officer | Sell | 11,139 | $9.94 | $110.7K | 193,128 |
| May 13, 2026 | Teel Randy | director, officer: President and CEO | Sell | 9,657 | $9.94 | $96.0K | 287,218 |
| May 13, 2026 | Berkowitz Noah | officer: Chief Medical Officer | Sell | 11,108 | $9.94 | $110.4K | 191,395 |
| May 13, 2026 | Cacace Angela M | officer: Chief Scientific Officer | Sell | 9,657 | $9.94 | $96.0K | 182,966 |
| Mar 19, 2026 | Berkowitz Noah | officer: Chief Medical Officer | Sell | 6,435 | $11.10 | $71.4K | 202,503 |
| Mar 9, 2026 | Morrison Briggs | director | Buy | 20,000 | $13.40 | $268.1K | 96,021+26% |
| Mar 2, 2026 | Houston John G | director | Sell | 35,297 | $13.21 | $466.2K | 1,152,792 |
| Feb 25, 2026 | Cacace Angela M | officer: Chief Scientific Officer | Sell | 3,609 | $12.16 | $43.9K | 150,194 |
| Feb 25, 2026 | Loomis David K | officer: Chief Accounting Officer | Sell | 1,108 | $12.16 | $13.5K | 29,692 |
| Feb 25, 2026 | Teel Randy | director, officer: President and CEO | Sell | 4,786 | $12.16 | $58.2K | 153,444 |
| Feb 13, 2026 | Berkowitz Noah | Chief Medical Officer | Sell | 5,685 | $11.89 | $67.6K | 0 |
| Feb 13, 2026 | Cacace Angela M | Chief Scientific Officer | Sell | 4,592 | $11.89 | $54.6K | 0 |
| Feb 13, 2026 | Loomis David K | Chief Accounting Officer | Sell | 1,016 | $11.89 | $12.1K | 0 |
| Feb 13, 2026 | Saik Andrew | Chief Financial Officer | Sell | 5,134 | $11.89 | $61.0K | 0 |
| Feb 13, 2026 | Teel Randy | President and CEO | Sell | 4,403 | $11.89 | $52.4K | 0 |
| Nov 7, 2025 | Loomis David K | Chief Accounting Officer | Sell | 230 | $9.89 | $2.3K | 0 |
| Sep 22, 2025 | Morrison Briggs | Director | Buy | 30,000 | $7.57 | $227.0K | 0 |
| Jun 24, 2025 | Saik Andrew | Chief Financial Officer | Sell | 5,700 | $7.61 | $43.4K | 0 |
| Jun 17, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | 2,583 | $7.49 | $19.3K | 0 |
| Mar 18, 2025 | Berkowitz Noah | Chief Medical Officer | Sell | 8,658 | $8.59 | $74.4K | 0 |
| Feb 24, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | 4,207 | $16.70 | $70.2K | 0 |
| Feb 24, 2025 | Houston John G | President and CEO | Sell | 31,338 | $16.72 | $523.9K | 0 |
| Feb 24, 2025 | Loomis David K | Chief Accounting Officer | Sell | 1,214 | $16.75 | $20.3K | 0 |
| Feb 24, 2025 | Taylor Ian | President, R&D | Sell | 9,020 | $16.71 | $150.8K | 0 |
| Feb 23, 2024 | Cassidy Sean A | Chief Financial Officer | Sell | 1,702 | $47.05 | $80.1K | 0 |
| Feb 23, 2024 | Houston John G | President and CEO | Sell | 5,196 | $47.05 | $244.5K | 0 |
| Feb 23, 2024 | Peck Ronald | Chief Medical Officer | Sell | 1,699 | $47.05 | $79.9K | 0 |
| Feb 23, 2024 | Taylor Ian | Chief Scientific Officer | Sell | 1,701 | $47.05 | $80.0K | 0 |
| Nov 8, 2023 | Loomis David K | Chief Accounting Officer | Sell | 460 | $22.39 | $10.3K | 0 |
| Aug 11, 2023 | Peck Ronald | Chief Medical Officer | Sell | 1,324 | $24.39 | $32.3K | 0 |
| Mar 1, 2023 | Cassidy Sean A | Chief Financial Officer | Sell | 1,745 | $29.53 | $51.5K | 0 |
| Mar 1, 2023 | Houston John G | President and CEO | Sell | 5,878 | $29.53 | $173.6K | 0 |
| Mar 1, 2023 | Taylor Ian | Chief Scientific Officer | Sell | 1,051 | $29.53 | $31.0K | 0 |
| Aug 12, 2022 | Peck Ronald | Chief Medical Officer | Sell | 1,258 | $68.99 | $86.8K | 0 |
| Apr 14, 2022 | Morrison Briggs | Director | Sell | 20,960 | $66.44 | $1.39M | 0 |
| Mar 11, 2022 | Cassidy Sean A | Chief Financial Officer | Sell | 15,000 | $70.00 | $1.05M | 0 |
| Feb 23, 2022 | Cassidy Sean A | Chief Financial Officer | Sell | 1,593 | $63.94 | $101.9K | 0 |
| Feb 23, 2022 | Houston John G | President and CEO | Sell | 6,024 | $63.94 | $385.2K | 0 |
| Feb 23, 2022 | Taylor Ian | Chief Scientific Officer | Sell | 869 | $63.94 | $55.6K | 0 |
| Feb 15, 2022 | Taylor Ian | Chief Scientific Officer | Sell | 20,000 | $73.02 | $1.46M | 0 |
| Jan 14, 2022 | Morrison Briggs | Director | Sell | 20,960 | $65.55 | $1.37M | 0 |
| Dec 30, 2021 | Peck Ronald | Chief Medical Officer | Sell | 20,000 | $80.61 | $1.61M | 0 |
| Dec 17, 2021 | Cassidy Sean A | Chief Financial Officer | Sell | 15,000 | $70.00 | $1.05M | 0 |
| Dec 14, 2021 | Ratcliffe Liam | Director | Sell | 355,705 | $67.00 | $23.83M0.6% OS | 0 |
| Nov 15, 2021 | Taylor Ian | Chief Scientific Officer | Sell | 20,000 | $84.04 | $1.68M | 0 |
| Nov 10, 2021 | Ratcliffe Liam | Director | Sell | 134,310 | $85.83 | $11.53M | 0 |
| Nov 5, 2021 | Ratcliffe Liam | Director | Sell | 172,079 | $93.02 | $16.01M | 0 |
| Nov 1, 2021 | Houston John G | President and CEO | Sell | 40,000 | $88.14 | $3.53M | 0 |
Showing 1–50 of 66
1 / 2
ARVN Insider Buying Activity
The following table shows recent insider purchases of Arvinas, Inc. (ARVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Morrison Briggs | director | Buy | 20,000 | $13.40 | $268.1K | 96,021+26% |
| Sep 22, 2025 | Morrison Briggs | Director | Buy | 30,000 | $7.57 | $227.0K | 0 |
ARVN Insider Selling Activity
The following table shows recent insider sales of Arvinas, Inc. (ARVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | Teel Randy | director, officer: President and CEO | Sell | 2,209 | $9.04 | $20.0K | 285,009 |
| May 13, 2026 | Loomis David K | officer: VP, Chief Accounting Officer | Sell | 1,919 | $9.94 | $19.1K | 40,193 |
| May 13, 2026 | Saik Andrew | officer: Chief Financial Officer | Sell | 11,139 | $9.94 | $110.7K | 193,128 |
| May 13, 2026 | Teel Randy | director, officer: President and CEO | Sell | 9,657 | $9.94 | $96.0K | 287,218 |
| May 13, 2026 | Berkowitz Noah | officer: Chief Medical Officer | Sell | 11,108 | $9.94 | $110.4K | 191,395 |
| May 13, 2026 | Cacace Angela M | officer: Chief Scientific Officer | Sell | 9,657 | $9.94 | $96.0K | 182,966 |
| Mar 19, 2026 | Berkowitz Noah | officer: Chief Medical Officer | Sell | 6,435 | $11.10 | $71.4K | 202,503 |
| Mar 2, 2026 | Houston John G | director | Sell | 35,297 | $13.21 | $466.2K | 1,152,792 |
| Feb 25, 2026 | Cacace Angela M | officer: Chief Scientific Officer | Sell | 3,609 | $12.16 | $43.9K | 150,194 |
| Feb 25, 2026 | Loomis David K | officer: Chief Accounting Officer | Sell | 1,108 | $12.16 | $13.5K | 29,692 |
| Feb 25, 2026 | Teel Randy | director, officer: President and CEO | Sell | 4,786 | $12.16 | $58.2K | 153,444 |
| Feb 13, 2026 | Berkowitz Noah | Chief Medical Officer | Sell | 5,685 | $11.89 | $67.6K | 0 |
| Feb 13, 2026 | Cacace Angela M | Chief Scientific Officer | Sell | 4,592 | $11.89 | $54.6K | 0 |
| Feb 13, 2026 | Loomis David K | Chief Accounting Officer | Sell | 1,016 | $11.89 | $12.1K | 0 |
| Feb 13, 2026 | Saik Andrew | Chief Financial Officer | Sell | 5,134 | $11.89 | $61.0K | 0 |
| Feb 13, 2026 | Teel Randy | President and CEO | Sell | 4,403 | $11.89 | $52.4K | 0 |
| Nov 7, 2025 | Loomis David K | Chief Accounting Officer | Sell | 230 | $9.89 | $2.3K | 0 |
| Jun 24, 2025 | Saik Andrew | Chief Financial Officer | Sell | 5,700 | $7.61 | $43.4K | 0 |
| Jun 17, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | 2,583 | $7.49 | $19.3K | 0 |
| Mar 18, 2025 | Berkowitz Noah | Chief Medical Officer | Sell | 8,658 | $8.59 | $74.4K | 0 |
| Feb 24, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | 4,207 | $16.70 | $70.2K | 0 |
| Feb 24, 2025 | Houston John G | President and CEO | Sell | 31,338 | $16.72 | $523.9K | 0 |
| Feb 24, 2025 | Loomis David K | Chief Accounting Officer | Sell | 1,214 | $16.75 | $20.3K | 0 |
| Feb 24, 2025 | Taylor Ian | President, R&D | Sell | 9,020 | $16.71 | $150.8K | 0 |
| Feb 23, 2024 | Cassidy Sean A | Chief Financial Officer | Sell | 1,702 | $47.05 | $80.1K | 0 |
| Feb 23, 2024 | Houston John G | President and CEO | Sell | 5,196 | $47.05 | $244.5K | 0 |
| Feb 23, 2024 | Peck Ronald | Chief Medical Officer | Sell | 1,699 | $47.05 | $79.9K | 0 |
| Feb 23, 2024 | Taylor Ian | Chief Scientific Officer | Sell | 1,701 | $47.05 | $80.0K | 0 |
| Nov 8, 2023 | Loomis David K | Chief Accounting Officer | Sell | 460 | $22.39 | $10.3K | 0 |
| Aug 11, 2023 | Peck Ronald | Chief Medical Officer | Sell | 1,324 | $24.39 | $32.3K | 0 |
| Mar 1, 2023 | Cassidy Sean A | Chief Financial Officer | Sell | 1,745 | $29.53 | $51.5K | 0 |
| Mar 1, 2023 | Houston John G | President and CEO | Sell | 5,878 | $29.53 | $173.6K | 0 |
| Mar 1, 2023 | Taylor Ian | Chief Scientific Officer | Sell | 1,051 | $29.53 | $31.0K | 0 |
| Aug 12, 2022 | Peck Ronald | Chief Medical Officer | Sell | 1,258 | $68.99 | $86.8K | 0 |
| Apr 14, 2022 | Morrison Briggs | Director | Sell | 20,960 | $66.44 | $1.39M | 0 |
| Mar 11, 2022 | Cassidy Sean A | Chief Financial Officer | Sell | 15,000 | $70.00 | $1.05M | 0 |
| Feb 23, 2022 | Cassidy Sean A | Chief Financial Officer | Sell | 1,593 | $63.94 | $101.9K | 0 |
| Feb 23, 2022 | Houston John G | President and CEO | Sell | 6,024 | $63.94 | $385.2K | 0 |
| Feb 23, 2022 | Taylor Ian | Chief Scientific Officer | Sell | 869 | $63.94 | $55.6K | 0 |
| Feb 15, 2022 | Taylor Ian | Chief Scientific Officer | Sell | 20,000 | $73.02 | $1.46M | 0 |
| Jan 14, 2022 | Morrison Briggs | Director | Sell | 20,960 | $65.55 | $1.37M | 0 |
| Dec 30, 2021 | Peck Ronald | Chief Medical Officer | Sell | 20,000 | $80.61 | $1.61M | 0 |
| Dec 17, 2021 | Cassidy Sean A | Chief Financial Officer | Sell | 15,000 | $70.00 | $1.05M | 0 |
| Dec 14, 2021 | Ratcliffe Liam | Director | Sell | 355,705 | $67.00 | $23.83M0.6% OS | 0 |
| Nov 15, 2021 | Taylor Ian | Chief Scientific Officer | Sell | 20,000 | $84.04 | $1.68M | 0 |
| Nov 10, 2021 | Ratcliffe Liam | Director | Sell | 134,310 | $85.83 | $11.53M | 0 |
| Nov 5, 2021 | Ratcliffe Liam | Director | Sell | 172,079 | $93.02 | $16.01M | 0 |
| Nov 1, 2021 | Houston John G | President and CEO | Sell | 40,000 | $88.14 | $3.53M | 0 |
ARVN Insiders
Similar Stocks to ARVN
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B